Vivmark Residential <VMRK.N>: Morgan Stanley resumes coverage with overweight rating; target price $75
VMRK•Related News
Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit
NAGE•
Northstrive Acquisition Corp I sponsor NorthStrive Sponsor I files initial beneficial ownership statement
NSAIU•
Popular Senior VP and Comptroller Denissa Rodriguez Adorno sells 600 shares for $101,271.6
BPOP•
Celcuity submits FDA sNDA for REVTORPYK in PIK3CA-mutant advanced breast cancer
CELC•
Brightline Interactive signs teaming agreement with CSCI for FAA eIPP LIFTOff Louisiana test site
BTLN•